Topic
Biotech Industry
1story
Biotech Industry
Enlivex Cuts 60% of Staff and Ends Preclinical R&D
Enlivex lays off 60% of staff, ends preclinical R&D and cuts executive salaries in a restructuring that leave…
Oct 19
The newsroom digest
One email a day with the stories that matter. No noise.